Sarah Zielsdorf, MD, MS - Polymicrobial Sepsis - 2022 Conference (LDN; low dose naltrexone)

Sarah Zielsdorf, MD, MS - Hashimoto's Thyroiditis - 2022 Conference (LDN; low dose naltrexone)

Sarah Zielsdorf, MD, MS - Attenuating Viral Pathogenesis with TLR and VitD Receptor Therapeutics - 2022 Conference (LDN; low dose naltrexone)

Leonard Weinstock, MD - Crohn's Disease and Ulcerative Colitis - 2022 Conference (LDN; low dose naltrexone)

Pamela Smith, MD, MPH, MS - Insulin Resistance & Diabetes - 2022 Conference (LDN; low dose naltrexone)

Armin Schwarzbach, MD, PhD - Lyme Testing - 2022 Conference (LDN; low dose naltrexone)

Yusuf Saleeby, MD - LDN Basics - 2022 Conference (LDN; low dose naltrexone)

Neel Mehta, MD - An Alternative to Opioids - 2022 Conference (LDN; low dose naltrexone)

Lauren Mathewson, ND - LDN Case Studies - 2022 Conference (LDN; low dose naltrexone)

Elizabeth Livengood, ND - Peptides - 2022 Conference (LDN; low dose naltrexone)